Infection prevention and control in cystic fibrosis

Lisa Saiman1

  • 1Department of Pediatrics, Columbia University, and Morgan Stanley Children's Hospital of NewYork-Presbyterian, New York, New York 10032, USA. LS5@columbia.edu

Abstract

Insights

Cystic Fibrosis (CF) pathogen virulence and transmission are complex. New findings on droplet nuclei challenge current infection control, like the 3-foot rule, and suggest masks may be needed for CF patients.

Area of Science:

  • Infectious Diseases
  • Pulmonary Medicine
  • Microbiology

Background:

  • Cystic Fibrosis (CF) is a genetic disorder affecting lungs and other organs.
  • Pathogen virulence and transmission dynamics are critical in CF patient care.
  • Methicillin-resistant Staphylococcus aureus (MRSA) and epidemic Pseudomonas aeruginosa strains increase morbidity and mortality in CF patients.

Purpose of the Study:

  • To review recent studies on CF pathogen virulence.
  • To examine droplet transmission complexities in CF settings.
  • To identify barriers to implementing infection control guidelines in CF clinics.

Main Methods:

  • Review of recent experimental and clinical data on CF pathogens.
  • Analysis of studies on bacterial contamination in CF clinics.
  • Investigation into transmission routes and infection control strategies.

Main Results:

  • MRSA and epidemic Pseudomonas aeruginosa strains are linked to increased CF morbidity and mortality.
  • Household contacts can harbor MRSA, affecting eradication success.
  • CF patients may generate infectious droplet nuclei, challenging the '3-foot rule' for transmission safety.

Conclusions:

  • Droplet nuclei findings suggest potential airborne transmission risks in CF settings.
  • Current infection control guidelines, including the '3-foot rule,' may need revision.
  • Further research is essential to enhance infection control practices for CF patients, families, and healthcare professionals.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...